Skip to Content

Golden Biotechnology Corp 4132

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4132 is trading at a 41% discount.
Price
TWD 28.17
Fair Value
TWD 69.27
Uncertainty
Extreme
1-Star Price
TWD 529.27
5-Star Price
TWD 6.54
Economic Moat
Zcj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4132 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
22.17
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Golden Biotechnology Corp is a Taiwan based company engages in the production of drugs and herbal supplement. It specializes in anti-cancer and anti-atherosclerosis drugs.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
122

Comparables

Valuation

Metric
4132
1701
6620
Price/Earnings (Normalized)
19.9324.88
Price/Book Value
6.650.886.91
Price/Sales
22.170.7616.43
Price/Cash Flow
11.7222.92
Price/Earnings
4132
1701
6620

Financial Strength

Metric
4132
1701
6620
Quick Ratio
1.240.8712.90
Current Ratio
1.881.6512.96
Interest Coverage
−36.617.383,488.96
Quick Ratio
4132
1701
6620

Profitability

Metric
4132
1701
6620
Return on Assets (Normalized)
−19.17%2.57%36.62%
Return on Equity (Normalized)
−27.94%4.40%39.46%
Return on Invested Capital (Normalized)
−20.77%3.43%38.19%
Return on Assets
4132
1701
6620
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AGgzxphgpZhwm$72.4 Bil
MKKGY
Merck KGaA ADRNsvzvxhcqZcnpsty$70.8 Bil
HLN
Haleon PLC ADRYqbylmrkFqcff$38.2 Bil
VTRS
Viatris IncPtbwtppbBdqx$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRGwzzfkggtSvx$12.5 Bil
CTLT
Catalent IncXtldjygwZzbyz$10.1 Bil
PRGO
Perrigo Co PLCHmcsbxggCwsdx$4.3 Bil
CURLF
Curaleaf Holdings IncMdfhgjsmTzlsh$3.7 Bil
PBH
Prestige Consumer Healthcare IncGsmkgnpKxvktbl$3.5 Bil
GTBIF
Green Thumb Industries IncFwnyjpnpbGkmw$2.9 Bil

Sponsor Center